DATE: October 30, 2018
TIME: 8:00am PDT, 11:00am EDT
Does your PSC medium support cell therapy? In this webinar, learn about Cell Therapy Systems™ (CTS™) Essential 8™ Medium, a feeder-free pluripotent stem cell (PSC) medium that has been designed to satisfy global regulatory requirements. CTS Essential 8 Medium uses the same formulation as the original research-use Essential 8 Medium as designed by the laboratory of James Thomson, but with human-and animal origin-free components. Here we describe the variety of ways in which CTS Essential 8 Medium reduces risks and facilitates regulatory filings. We also lay out other products that can support the PSC-derived cell therapy workflows along with CTS Essential 8 Medium. In the second part of the webinar, we present application data as well as data comparing the performance of CTS Essential 8 with research-use Essential 8 Medium so that you can be confident in making a seamless transition to the clinic.
- Benefits of using CTS Essential 8 Medium for translational and clinical research
- Differences and similarities between CTS Essential 8 Medium and research-use Essential 8 Medium
- Reagents and applications compatible with CTS Essential 8 Medium